Breast cancer is a heterogeneous disease that can be classified into molecular subtypes based on histologically determined markers, largely the expression status of the estrogen receptor (ER), progesterone receptor (PR), as well as human epidermal growth factor (HER2) [1,2,3]. Here, PGR is linked to breast carcinoma.